<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Incostra blog</title>
    <link>https://blog.incostra.com/incostra-blog</link>
    <description>Expert guides on anti-aging, hair restoration, and medical tourism in India for European patients</description>
    <language>en-us</language>
    <pubDate>Thu, 19 Nov 2026 06:34:00 GMT</pubDate>
    <dc:date>2026-11-19T06:34:00Z</dc:date>
    <dc:language>en-us</dc:language>
    <item>
      <title>Batch Record Review by Exception: Where AI Fits and Where It Does Not | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/batch-record-review-by-exception-ai</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/batch-record-review-by-exception-ai" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="Batch Record Review by Exception: Where AI Fits and Where It Does Not | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h1&gt;Batch Record Review by Exception: Where AI Fits and Where It Does Not&lt;/h1&gt; 
&lt;p&gt;Batch record review often sits between a finished batch and its release. Reviewers read through pages of entries, calculations and attachments to confirm that the batch was made and tested as intended. Most of those pages contain nothing unusual, yet every one has to be checked. Review by exception aims to change that.&lt;/p&gt;</description>
      <content:encoded>&lt;h1&gt;Batch Record Review by Exception: Where AI Fits and Where It Does Not&lt;/h1&gt; 
&lt;p&gt;Batch record review often sits between a finished batch and its release. Reviewers read through pages of entries, calculations and attachments to confirm that the batch was made and tested as intended. Most of those pages contain nothing unusual, yet every one has to be checked. Review by exception aims to change that.&lt;/p&gt; 
&lt;h2&gt;The idea behind review by exception&lt;/h2&gt; 
&lt;p&gt;Instead of reading every entry with equal attention, the process separates routine, in-limit data from anything that needs a person's judgement. Reviewers then spend their time on the exceptions: out-of-range values, missing entries, unexpected sequences and unresolved comments.&lt;/p&gt; 
&lt;h2&gt;What AI can check reliably&lt;/h2&gt; 
&lt;ul&gt;
 &lt;li&gt;&lt;strong&gt;Completeness:&lt;/strong&gt; missing signatures, blank fields and skipped steps.&lt;/li&gt;
 &lt;li&gt;&lt;strong&gt;Consistency:&lt;/strong&gt; values that disagree between the record, equipment logs and the LIMS.&lt;/li&gt;
 &lt;li&gt;&lt;strong&gt;Limits and calculations:&lt;/strong&gt; entries outside defined ranges, and arithmetic that does not reconcile.&lt;/li&gt;
 &lt;li&gt;&lt;strong&gt;Legibility and transcription:&lt;/strong&gt; comparing scanned handwritten entries against electronic source data.&lt;/li&gt;
&lt;/ul&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Ready to explore your options?&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;Want to see where your batch record review time goes? Book a free consultation.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Book a Free Consultation&lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;What stays with people&lt;/h2&gt; 
&lt;p&gt;Deciding whether a deviation affects product quality, and releasing the batch, remain decisions for the quality unit. AI should produce a prioritised list of findings with links to the evidence, never a release decision. Reviewers should also sample the routine pages so that the exception logic is itself checked over time.&lt;/p&gt; 
&lt;h2&gt;Getting started&lt;/h2&gt; 
&lt;ol&gt;
 &lt;li&gt;Pick one product family with a stable process and a clean history.&lt;/li&gt;
 &lt;li&gt;Run the AI checks in parallel with the normal review for a period and compare what each catches.&lt;/li&gt;
 &lt;li&gt;Measure review time, findings per record and anything the AI missed.&lt;/li&gt;
 &lt;li&gt;Document the intended use and the human review step before relying on it.&lt;/li&gt;
&lt;/ol&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Start your journey with Incostra&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;We help pharma quality teams shorten review cycles without weakening control. Let's talk about your process.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Get Your Free Consultation&lt;/a&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fbatch-record-review-by-exception-ai&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Thu, 19 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/batch-record-review-by-exception-ai</guid>
      <dc:date>2026-11-19T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
    <item>
      <title>Why AI in Pharma Needs a Semantic Layer, Not Just More Data | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/semantic-layer-knowledge-graph-pharma-ai</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/semantic-layer-knowledge-graph-pharma-ai" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="Why AI in Pharma Needs a Semantic Layer, Not Just More Data | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h1&gt;Why AI in Pharma Needs a Semantic Layer, Not Just More Data&lt;/h1&gt; 
&lt;p&gt;Many pharma AI pilots stall for the same reason: the model can read the data but does not understand it. "Batch", "lot", "site" and "deviation" mean slightly different things in different systems, and an AI agent has no way to know which meaning applies. A semantic layer fixes that by giving data a shared, machine-readable meaning.&lt;/p&gt;</description>
      <content:encoded>&lt;h1&gt;Why AI in Pharma Needs a Semantic Layer, Not Just More Data&lt;/h1&gt; 
&lt;p&gt;Many pharma AI pilots stall for the same reason: the model can read the data but does not understand it. "Batch", "lot", "site" and "deviation" mean slightly different things in different systems, and an AI agent has no way to know which meaning applies. A semantic layer fixes that by giving data a shared, machine-readable meaning.&lt;/p&gt; 
&lt;h2&gt;What a semantic layer is&lt;/h2&gt; 
&lt;p&gt;A semantic layer sits above your databases and documents. It defines the business concepts (products, batches, equipment, methods, deviations), how they relate and how they map to the underlying tables and fields. When those relationships are modelled explicitly as an ontology or knowledge graph, both people and AI agents can ask questions in business terms.&lt;/p&gt; 
&lt;h2&gt;What goes wrong without one&lt;/h2&gt; 
&lt;ul&gt; 
 &lt;li&gt;Different teams calculate the same metric differently, and AI answers inherit the confusion.&lt;/li&gt; 
 &lt;li&gt;Agents join the wrong tables because nothing tells them which fields really refer to the same thing.&lt;/li&gt; 
 &lt;li&gt;Answers cannot be explained, since there is no defined path from the question to the data used.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;h2&gt;What it enables&lt;/h2&gt; 
&lt;ul&gt; 
 &lt;li&gt;&lt;strong&gt;Consistent answers:&lt;/strong&gt; one definition of each metric used by dashboards and AI agents alike.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Explainability:&lt;/strong&gt; results can show which concepts and sources they came from.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Reusable context:&lt;/strong&gt; new AI use cases, from investigation copilots to document drafting, start from the same model of your business.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Ready to explore your options?&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;Curious what a semantic layer would look like over your data stack? Book a free consultation.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Book a Free Consultation&lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;How to start without a big-bang project&lt;/h2&gt; 
&lt;ol&gt; 
 &lt;li&gt;Choose one process, such as deviation management, and list the 10 to 20 concepts it depends on.&lt;/li&gt; 
 &lt;li&gt;Agree definitions with the business owners and map them to source fields.&lt;/li&gt; 
 &lt;li&gt;Expose the model to a first AI use case and test whether answers become more consistent.&lt;/li&gt; 
 &lt;li&gt;Extend to neighbouring processes once the first one is trusted.&lt;/li&gt; 
&lt;/ol&gt; 
&lt;p&gt;The model stays valuable as systems change, because the meaning of the data is captured in one governed place.&lt;/p&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Start your journey with Incostra&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;We help pharma teams build the data foundations that make AI useful and trustworthy. Talk to us.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Get Your Free Consultation&lt;/a&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fsemantic-layer-knowledge-graph-pharma-ai&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Fri, 13 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/semantic-layer-knowledge-graph-pharma-ai</guid>
      <dc:date>2026-11-13T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
    <item>
      <title>Validating AI Tools in GxP: Part 11, Annex 11 and a Risk-Based Approach | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/validating-ai-tools-part-11-annex-11-csa</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/validating-ai-tools-part-11-annex-11-csa" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="Validating AI Tools in GxP: Part 11, Annex 11 and a Risk-Based Approach | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt;</description>
      <content:encoded>&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fvalidating-ai-tools-part-11-annex-11-csa&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Thu, 12 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/validating-ai-tools-part-11-annex-11-csa</guid>
      <dc:date>2026-11-12T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
    <item>
      <title>Automating the APQR: Turning an Annual Scramble into a Continuous Process | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/automating-apqr-pqr-with-ai</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/automating-apqr-pqr-with-ai" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="Automating the APQR: Turning an Annual Scramble into a Continuous Process | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h1&gt;Automating the APQR: Turning an Annual Scramble into a Continuous Process&lt;/h1&gt; 
&lt;p&gt;The Annual Product Quality Review (APQR), known in Europe as the Product Quality Review (PQR), is a regulatory expectation: US GMP requires a periodic review of records to evaluate quality standards (21 CFR 211.180(e)), and EU GMP Chapter 1 requires regular reviews of every medicinal product. In many plants it is also a recurring scramble, with weeks spent collecting data from several systems and pasting it into a document.&lt;/p&gt;</description>
      <content:encoded>&lt;h1&gt;Automating the APQR: Turning an Annual Scramble into a Continuous Process&lt;/h1&gt; 
&lt;p&gt;The Annual Product Quality Review (APQR), known in Europe as the Product Quality Review (PQR), is a regulatory expectation: US GMP requires a periodic review of records to evaluate quality standards (21 CFR 211.180(e)), and EU GMP Chapter 1 requires regular reviews of every medicinal product. In many plants it is also a recurring scramble, with weeks spent collecting data from several systems and pasting it into a document.&lt;/p&gt; 
&lt;h2&gt;Why the APQR is so manual&lt;/h2&gt; 
&lt;ul&gt; 
 &lt;li&gt;Data lives in the LIMS, MES, QMS, ERP and stability systems, each with its own export format.&lt;/li&gt; 
 &lt;li&gt;Trends are calculated in spreadsheets, so each product and year is rebuilt from scratch.&lt;/li&gt; 
 &lt;li&gt;Commentary has to be written for every section: batch yield, deviations, OOS, complaints, change controls, stability and more.&lt;/li&gt; 
 &lt;li&gt;Reviewers must check that every number in the narrative matches its source.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;h2&gt;What can be automated&lt;/h2&gt; 
&lt;p&gt;Treat the APQR as a structured data product, not a document you write once a year.&lt;/p&gt; 
&lt;ol&gt; 
 &lt;li&gt;&lt;strong&gt;Data collection:&lt;/strong&gt; scheduled extracts from source systems into a governed dataset, refreshed continuously rather than annually.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Tables and trend charts:&lt;/strong&gt; generated from that dataset using fixed, versioned logic.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Draft commentary:&lt;/strong&gt; AI proposes a summary of each section from the data, citing the records it used.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Reconciliation checks:&lt;/strong&gt; automated comparison of narrative figures against source values before review.&lt;/li&gt; 
&lt;/ol&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Ready to explore your options?&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;Find out how much of your APQR cycle could be automated. Book a free consultation.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Book a Free Consultation&lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;Keeping the review meaningful&lt;/h2&gt; 
&lt;p&gt;The point of an APQR is to spot trends and decide on actions. Automation should free reviewers to spend their time on that judgement. The quality unit still reviews, edits and approves the final report, and the AI-drafted text should be clearly marked as a draft until they do.&lt;/p&gt; 
&lt;h2&gt;A side benefit&lt;/h2&gt; 
&lt;p&gt;When APQR data is refreshed continuously, a drifting process shows up during the year, not in the following review. The report becomes a by-product of monitoring you already do.&lt;/p&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Start your journey with Incostra&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;We help pharma teams automate quality documentation without losing control of the content. Talk to us.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Get Your Free Consultation&lt;/a&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fautomating-apqr-pqr-with-ai&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Wed, 11 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/automating-apqr-pqr-with-ai</guid>
      <dc:date>2026-11-11T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
    <item>
      <title>AI Copilots for Deviation and OOS Investigations: What Good Looks Like | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/ai-copilot-deviation-oos-investigations</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/ai-copilot-deviation-oos-investigations" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="AI Copilots for Deviation and OOS Investigations: What Good Looks Like | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h1&gt;AI Copilots for Deviation and OOS Investigations: What Good Looks Like&lt;/h1&gt; 
&lt;p&gt;Deviation and out-of-specification (OOS) investigations consume a large share of quality teams' time. Most of that time is not scientific judgement. It is gathering records, finding similar past events, drafting the narrative and chasing signatures. This is the part an AI copilot can help with, provided it is designed for a regulated environment.&lt;/p&gt;</description>
      <content:encoded>&lt;h1&gt;AI Copilots for Deviation and OOS Investigations: What Good Looks Like&lt;/h1&gt; 
&lt;p&gt;Deviation and out-of-specification (OOS) investigations consume a large share of quality teams' time. Most of that time is not scientific judgement. It is gathering records, finding similar past events, drafting the narrative and chasing signatures. This is the part an AI copilot can help with, provided it is designed for a regulated environment.&lt;/p&gt; 
&lt;h2&gt;What a copilot should do&lt;/h2&gt; 
&lt;ul&gt; 
 &lt;li&gt;&lt;strong&gt;Assemble context.&lt;/strong&gt; Pull the batch record, equipment logs, training records and related events into one view.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Find similar events.&lt;/strong&gt; Surface past deviations with comparable symptoms and the root causes that were confirmed.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Draft, not decide.&lt;/strong&gt; Propose an investigation outline, a timeline and candidate root-cause hypotheses for the investigator to test.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Check completeness.&lt;/strong&gt; Highlight missing sections, unanswered questions and inconsistent dates before review.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;h2&gt;What it should not do&lt;/h2&gt; 
&lt;p&gt;US regulations require that unexplained discrepancies and OOS results are thoroughly investigated, and that the investigation is documented (see 21 CFR 211.192). The conclusion and its justification belong to qualified people. A copilot that auto-closes investigations or picks a root cause without human review creates more risk than it removes.&lt;/p&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Ready to explore your options?&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;See how a deviation copilot could fit your QMS. Book a free consultation with our team.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Book a Free Consultation&lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;Design principles for regulated use&lt;/h2&gt; 
&lt;ol&gt; 
 &lt;li&gt;&lt;strong&gt;Human in the loop by default.&lt;/strong&gt; Every suggestion is reviewed and accepted or rejected by a named person.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Show the evidence.&lt;/strong&gt; Each statement links back to the source record, so reviewers can verify it rather than trust it.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Keep an audit trail.&lt;/strong&gt; Record the prompt, the sources used, the output and the reviewer's decision.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Measure it.&lt;/strong&gt; Track investigation cycle time, rework at QA review and how often suggestions are accepted.&lt;/li&gt; 
&lt;/ol&gt; 
&lt;h2&gt;Starting small&lt;/h2&gt; 
&lt;p&gt;Many teams begin with one deviation category, such as laboratory events or documentation errors. A narrow scope makes it easier to validate the approach, build trust with reviewers and show a measurable gain before expanding.&lt;/p&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Start your journey with Incostra&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;We build AI workflows for pharma quality teams, with accountability and audit trails designed in. Let's talk.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Get Your Free Consultation&lt;/a&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fai-copilot-deviation-oos-investigations&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Tue, 10 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/ai-copilot-deviation-oos-investigations</guid>
      <dc:date>2026-11-10T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
    <item>
      <title>Data Lineage Across LIMS, MES and QMS: Why Pharma Audits Depend on It | Incostra</title>
      <link>https://blog.incostra.com/incostra-blog/data-lineage-lims-mes-qms-pharma</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://blog.incostra.com/incostra-blog/data-lineage-lims-mes-qms-pharma" title="" class="hs-featured-image-link"&gt; &lt;img src="https://blog.incostra.com/hubfs/Data%20and%20AI%20featured%20image.jpg" alt="Data Lineage Across LIMS, MES and QMS: Why Pharma Audits Depend on It | Incostra" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt; 
&lt;h1&gt;Data Lineage Across LIMS, MES and QMS: Why Pharma Audits Depend on It&lt;/h1&gt; 
&lt;p&gt;Ask a quality head how long it takes to trace one batch from raw material receipt to release, and the answer is rarely "minutes". The evidence sits in a LIMS, an MES, a QMS, a document system and, often, a few spreadsheets. Each system is validated on its own. The gaps between them are where investigations slow down and inspectors start asking questions.&lt;/p&gt;</description>
      <content:encoded>&lt;h1&gt;Data Lineage Across LIMS, MES and QMS: Why Pharma Audits Depend on It&lt;/h1&gt; 
&lt;p&gt;Ask a quality head how long it takes to trace one batch from raw material receipt to release, and the answer is rarely "minutes". The evidence sits in a LIMS, an MES, a QMS, a document system and, often, a few spreadsheets. Each system is validated on its own. The gaps between them are where investigations slow down and inspectors start asking questions.&lt;/p&gt; 
&lt;h2&gt;What data lineage means in a GxP setting&lt;/h2&gt; 
&lt;p&gt;Data lineage is the ability to show where a data point came from, what happened to it, and who or what changed it, across every system it touched. For regulated data this is closely tied to the ALCOA+ principles: attributable, legible, contemporaneous, original, accurate, and also complete, consistent, enduring and available.&lt;/p&gt; 
&lt;h2&gt;Where lineage breaks in practice&lt;/h2&gt; 
&lt;ul&gt; 
 &lt;li&gt;&lt;strong&gt;Identifiers do not match.&lt;/strong&gt; A batch is "B-2041" in the MES, "2041/A" in the LIMS and a free-text reference in a deviation record.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Manual transcription.&lt;/strong&gt; Results retyped between systems create copies that nobody can prove are identical to the original.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Transformations are invisible.&lt;/strong&gt; Spreadsheets and ad hoc reports calculate values with no record of the logic used.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Context is lost.&lt;/strong&gt; A result is stored without the method version, instrument or sample plan that explains it.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;h2&gt;A practical approach&lt;/h2&gt; 
&lt;p&gt;You do not need to replace your systems to fix this. Start with the questions your team asks most often during investigations and audits, then work backwards.&lt;/p&gt; 
&lt;ol&gt; 
 &lt;li&gt;&lt;strong&gt;Agree a canonical identifier model&lt;/strong&gt; for batches, materials, equipment, methods and people, and map each system's identifiers to it.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Integrate at the source&lt;/strong&gt; through interfaces or a governed data layer, instead of exporting and re-keying.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Capture transformations as code or configuration&lt;/strong&gt;, versioned and reviewable, not as hidden spreadsheet logic.&lt;/li&gt; 
 &lt;li&gt;&lt;strong&gt;Keep the audit trail connected.&lt;/strong&gt; The trail from each source system should remain reachable from the integrated view.&lt;/li&gt; 
&lt;/ol&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Ready to explore your options?&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;Book a free consultation to discuss how connected data could shorten your investigations.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Book a Free Consultation&lt;/a&gt; 
&lt;/div&gt; 
&lt;h2&gt;Where AI helps, and where it does not&lt;/h2&gt; 
&lt;p&gt;Once identifiers and sources are connected, AI can do useful work on top: assembling the timeline for an investigation, flagging records that do not reconcile, or answering "which batches used this lot?" in seconds. Without that foundation, AI simply reproduces the inconsistencies it is fed. Lineage comes first, and the AI comes after.&lt;/p&gt; 
&lt;h2&gt;Questions to ask your team this week&lt;/h2&gt; 
&lt;p&gt;Pick one recent deviation. How many systems did the investigator open, and how long did it take to reconstruct the timeline? That number is your baseline, and it is usually a persuasive argument for investing in the data foundation.&lt;/p&gt; 
&lt;div style="background:#E8F5E9;border:2px solid #2E7D32;padding:20px;margin:30px 0;border-radius:4px;"&gt; 
 &lt;p style="font-weight:bold;color:#1B2A4A;margin:0 0 8px;"&gt;Start your journey with Incostra&lt;/p&gt; 
 &lt;p style="margin:0 0 12px;"&gt;We help pharma quality and manufacturing teams build the data foundations AI needs. Talk to us about your landscape.&lt;/p&gt; 
 &lt;a href="https://www.incostra.com/contact" style="background:#2E7D32;color:#fff;padding:10px 20px;text-decoration:none;border-radius:4px;"&gt;Get Your Free Consultation&lt;/a&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=242363506&amp;amp;k=14&amp;amp;r=https%3A%2F%2Fblog.incostra.com%2Fincostra-blog%2Fdata-lineage-lims-mes-qms-pharma&amp;amp;bu=https%253A%252F%252Fblog.incostra.com%252Fincostra-blog&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <pubDate>Mon, 09 Nov 2026 04:30:00 GMT</pubDate>
      <guid>https://blog.incostra.com/incostra-blog/data-lineage-lims-mes-qms-pharma</guid>
      <dc:date>2026-11-09T04:30:00Z</dc:date>
      <dc:creator>Sarah</dc:creator>
    </item>
  </channel>
</rss>
